Tag: university
-
Cancer Drugs Shown With Potential Against HIV-Related Fungus
11 February 2014. Medical researchers at University of Rochester in New York found two drugs treating breast cancer have properties that point to their potential as a treatment for Cryptococcus, a fungus causing meningitis in people with HIV/AIDS. The team led by Rochester’s Damian Krysan, with colleagues from Temple and Duke universities and University of…
-
Belgium-U.S. Consortium Developing Lung Image Technology
11 February 2014. A group of companies and universities in Belgium and the U.S. are collaborating on an advanced imaging technology to spot signs of lung transplant rejection earlier in a patient’s recovery. Fluidda nv in Kontich, Belgium is leading the collaboration, with additive manufacturing company Materialise in Leuven, Belgium, and universities in Belgium (University…
-
Engineered Hemp Delivers High Volume of Healthy Oleic Acid
10 February 2014. Biologists at University of York in the U.K. developed a new form of hemp plant that produces seeds with oil containing a high volume of oleic acid, a nutritious fatty acid like that found in olive oil. The team led by York’s Ian Graham, who heads the university’s biology department, published its…
-
Xerox Testing Video to Monitor Patient Vital Signs
6 February 2014. Engineers at Xerox Corporation research centers in Bangalore, India and Webster, New York are testing the feasibility of video sensing combined with data analytics to track the status of patients with chronic conditions. The project is led by Xerox research fellow Lalit Mestha in Webster. The techniques tested by Xerox use video…
-
Calif Stem Cell, UC Irvine Partner on Eye Transplant Tissue
6 February 2014. California Stem Cell Inc. in Irvine and University of California in Irvine are researching the creation of retinal tissue from stem cells for transplants in patients with incurable retinal disorders, such as age-related macular degeneration and retinitis pigmentosa. The study is funded by a $4 million grant from the California Institute of…
-
Sense of Touch Restored to Amputee’s Prosthetic Hand
5 February 2014. Biomedical engineers and computer scientists at Ecole Polytechnique Federale de Lausanne (EPFL) in Switzerland developed a sensory feedback system for an amputee’s prosthetic hand to control grasping and sense stiffness and shapes of objects. The findings of the Lifehand 2 team led by EPFL’s Silvestro Micera, with colleagues from other institutions in Europe,…
-
NSF-Funded Research Studying Robot-Human Interaction
3 February 2014. Computer scientists at Worcester Polytechnic Institute in Massachusetts are researching interactions between humans and robots in factory and home settings, working either as collaborators with or helpers to people. Research by Worcester Tech faculty Dmitry Berenson and Sonia Chernova, is funded by a pair of three-year grants from National Science Foundation’s National…
-
Football Helmet Design Shown to Reduce Concussion Risk
31 January 2014. Biomedical engineers at Virginia Tech in Blacksburg found a helmet design that better absorbs head impact can reduce the rate of concussions among college football players. The team led by Virginia Tech research professor Steve Rowson, with colleagues from seven other institutions, published its findings online today in Journal of Neurosurgery. Recent…
-
Early Trial Finds Vaccine Booster Covers Pandemic Flu Types
30 January 2014. An early-stage clinical trial shows an RNA agent being developed by Hemispherx Biopharma in Philadelphia extends the effectiveness of the standard nasal flu vaccine to cover pandemic influenza strains, like those found in Pacific Rim countries. Results of the trial were presented yesterday at a meeting of the American Society for Microbiology…
-
Biopharma, University Partner on Blood Cancer Immunotherapy
29 January 2014. Kiadis Pharma B.V., a biopharmaceutical company in Amsterdam, is collaborating with a research group at Technical University of Munich to identify immune-system cells for treating leukemia in the company’s immunotherapy product for blood cancers. Financial aspects of the partnership were not disclosed, although the company says the Munich research is funded, at…